Gain of Function (GoF) mutations in N-RAS and B-RAF are common drivers for melanoma development (~ 25% for N-RAS and ~ 60% for B-RAF) as they are responsible for dysregulated cell cycle and proliferation [31–35]. Here, BRAF is linked to melanoma.